NeuroSense Therapeutics
well balanced enrollment phase study | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
15 of 33
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
December 2023
well balanced enrollment | NeuroSense Therapeutics
Related slides by other companies
Myovant Sciences
Results
August 2022
change from in lumbar spine at month in pooled data from spirit and studies | Myovant Sciences
9 Meters Biopharma
Investor Presentation
September 2022
relative change from placebo | 9 Meters Biopharma
Dare Bioscience
Investor Presentation
February 2023
dar working to accelerate innovation in women health upcoming program milestones dare | Dare Bioscience
Erasca
Investor Presentation
November 2023
clinical activity of in melanoma was reproducible across phase and phase studies a | Erasca
Other recent decks by NeuroSense Therapeutics
See all presentations (3 decks)
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io